Knee osteoarthritis represents 92.0% of the indication category, three-injection regimens account for 47.8% of product type demand and ambulatory surgical centers hold 32.1%, orthopedic clinics 25.5% of end-user sales in 2026. The knee hyaluronic acid injections market is projected to post a 5.6% CAGR between 2026 and 2036.